Henry Schein Inc

Henry Schein Inc has a market price of $72.99 and a market cap of $8.37 billion, with a price-to-earnings ratio of 80.53 and a price-to-book ratio of 2.38. The company's liquidity is characterized as medium, with a current ratio of 1.55 and a debt-to-equity ratio of 0.71. The company's free cash flow is $125 million, and its operating cash flow is $493 million, indicating a moderate level of liquidity. In terms of profitability, Henry Schein Inc has a return on equity of 2.96% and a return on assets of 1.01%. These figures are below the industry median for return on equity and return on assets, suggesting that the company is underperforming in terms of profitability relative to its peers. The company's operating income is $159 million, and its net income is $104 million, with a gross profit of $1.02 billion. Henry Schein Inc's revenue is concentrated in the healthcare services and equipment sector, with a significant portion derived from the distribution of medical equipment and supplies. The company's geographic exposure is primarily in the United States, with a smaller presence in international markets. The company's revenue concentration in a single sector and region may pose a risk to its financial stability in the event of sector-specific or regional economic downturns. The company's growth trajectory is expected to be modest, with a revenue outlook that is projected to remain stable in the current fiscal year and show slight growth in the next fiscal year. The company's capital expenditure is negative, indicating a reduction in investment in physical assets, which may affect its long-term growth potential. The company's operating income and net income are expected to remain relatively flat, with no significant changes anticipated in the near term. The company's risk assessment indicates a medium level of liquidity risk and a low level of dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may face challenges in maintaining its liquidity position. The company's debt-to-equity ratio of 0.71 indicates a moderate level of leverage, which may increase its financial risk in the event of rising interest rates or economic downturns. Recent events and filings indicate that the company has a strong analyst following, with a mean price target of $90.26 and a median price target of $89.50. The company has received a mix of strong-buy, buy, and hold recommendations from analysts, with a mean recommendation of 2.33. The company's recent financial performance and analyst sentiment suggest that it is well-positioned to maintain its market position and continue to generate stable returns for investors.